Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-62.69	28.38	76.07
Graham Fair Price	829.73	19891.41	2139.48
PEG	-99.99	< 0.005	11.41
Price/Book	-11.58	1.47	1.67
Price/Cash Flow	-6.06	50.02	53.25
Prices/Earnings	-98.94	12.19	-1153.49
Price/Sales	-22.64	4.95	6.40
Price/FCF	-6.06	50.02	53.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	43.93	0.19	0.13
Operating Margin	1262.85	0.10	< 0.005
ROA	8052.83	0.02	< 0.005
ROE	< 0.005	0.03	8265.00
ROIC	< 0.005	0.02	12698.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.53	-0.07	-638.98
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-1.05	16.84	1498.90
EPS QOQ	-1.01	86.05	8414.99
FCF QOQ	11.11	-0.04	-99.61
Revenue QOQ	-0.15	0.16	6.66
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	59.56	60.06	0.84
Days Sales Outstanding (DSO)	92.26	94.60	2.53
Inventory Turnover	1.51	1.50	-0.83
Debt/Capitalization	0.03	0.02	-52.97
Quick Ratio	2.48	2.29	-7.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23733.30	24125.88	1.65
Cash	6895.12	6774.09	-1.76
Capex	-751.11	-274.90	63.40
Free Cash Flow	742.77	710.75	-4.31
Revenue	6175.78	7175.72	16.19
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.24	3.00	-7.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.64	-2.23	60.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating